• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves New Nasal Spray for Migraines

The New York Times – Business:

Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Lancet Neurology, The (Journal), Migraine Headaches, Nerves and Nervous System, Pfizer Inc
←RuPaul Shreds ‘Stunt Queen’ Politicians Pushing To Ban Drag Shows In Fiery Video
Michael Tilson Thomas Revels in the Present With the New York Phil→

More posts

  • Why This Josie Maran Body Butter is My Holy Grail 

  • Aluminium, Helium and Sulfur: The Iran War Is Affecting More Than Oil

  • Senate Moves Toward Passing Sweeping Housing Bill, but Challenges Lie Ahead

  • Girl, Log Off: A Guide To Recharging On National Day Of Rest For Black Women

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube